{"id":"W2979430133","doi":"10.1182/blood.v106.11.447.447","title":"Results of Phase II Study of Lenalidomide (L) {Revlimid®} in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL).","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Lenalidomide; Medicine; Thalidomide; Internal medicine; Rituximab; Neutropenia; Gastroenterology; Bendamustine; Chronic lymphocytic leukemia; Pomalidomide; Refractory (planetary science); Multiple myeloma; Progressive disease; Phases of clinical research; Oncology; Immunology; Toxicity; Leukemia; Lymphoma; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002833215,0.001250782,0.002101413,0.0003589371,0.0005649792,0.0009138205,0.0008048472,0.001216129,0.002343893],"category_scores_gemma":[0.001170767,0.0006101737,0.001093362,0.0003185221,0.0007643733,0.000707095,0.0004126585,0.002188071,0.001008647],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007978072,"about_ca_system_score_gemma":0.001247652,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008548917,"about_ca_topic_score_gemma":0.001313608,"domain_scores_codex":[0.999122,0.0005066952,0.00006456982,0.0001002981,0.00006303551,0.0001435023],"domain_scores_gemma":[0.9989855,0.0002137843,0.0001479861,0.00008155875,0.00006857791,0.0005025555],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6215286,0.1165142,0.03870461,0.001286588,0.001859077,0.001184499,0.0007811033,0.002291149,0.07098226,0.0002373167,0.004846056,0.1397845],"study_design_scores_gemma":[0.350552,0.595993,0.04256172,0.0000591012,0.000640559,0.0007154084,0.0001148732,0.0006981448,0.003812074,0.0001278769,0.004684861,0.0000403827],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9892733,0.003269781,0.0005384268,0.0004376857,0.0001166678,0.00324696,0.001274329,0.0000857779,0.001757139],"genre_scores_gemma":[0.9872993,0.001593671,0.001458791,0.001143339,0.0002131523,0.002936326,0.003169635,0.00003037638,0.002155483],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002833215,"threshold_uncertainty_score":0.01498365,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01896449986318711,"score_gpt":0.2976178362957274,"score_spread":0.2786533364325403,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}